Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | BIO BIOB | Bio-Rad A Common Stock | 432,920 | Mar 8, 2024 | Direct | ||||||
holding | BIO BIOB | Bio-Rad B Common Stock | 361,409 | Mar 8, 2024 | Direct | ||||||
holding | BIO BIOB | Bio-Rad B Common Stock | 12,949 | Mar 8, 2024 | By Spouse | F1 | |||||
holding | BIO BIOB | Bio-Rad B Common Stock | 4,060,054 | Mar 8, 2024 | By Blue Raven Partners, L.P. | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Non-Qualified Stock Option (right to buy) | +Grant/Award | $0 | +14,137 | $0.00 | 14,137 | Mar 8, 2024 | Bio-Rad A Common Stock | 14,137 | $343.76 | Direct | F3 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of these shares. |
F2 | The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
F3 | The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. |